Emerit M B, Gozlan H, Hall M D, Hamon M, Marquet A
Biochem Pharmacol. 1985 Mar 15;34(6):883-92. doi: 10.1016/0006-2952(85)90770-1.
We have synthesized 8-methoxy-2-(N-2'-chloropropyl, N-propyl) aminotetralin (8-methoxy-2'-chloro-PAT), an alkylating agent derived from the potent 5-HT agonist, 8-hydroxy-2-(N,N-dipropyl)-aminotetralin (PAT). As expected for an irreversible ligand, the blockade of 3H-PAT or 3H-5-HT binding to post-synaptic 5-HT1 (A and B) sites in rat hippocampal membranes pretreated with 8-methoxy-2'-chloro-PAT could not be prevented by extensive washing of membranes. Prior occupancy of 5-HT1 sites by 5-HT or PAT prevented any subsequent irreversible blockade by the alkylating agent. Similar irreversible blockade by 8-methoxy-2'-chloro-PAT was found on 3H-PAT binding to striatal membranes suggesting that presynaptic 5-HT binding sites (see Gozlan et al., Nature, Lond. 305, 140, 1983) were sensitive also to the alkylating agent. In contrast, the modifying agent N-ethylmaleimide (NEM) reduced markedly 3H-PAT binding to postsynaptic hippocampal 5-HT1 sites, but did not alter 3H-PAT binding to striatal presynaptic 5-HT sites. Although 8-methoxy-2'-chloro-PAT bound irreversibly to different classes of 5-HT binding sites (5-HT1A, 5-HT1B, presynaptic sites), it can be considered a selective alkylating agent, since it exerted no action on 3H-spiperone binding to 5-HT2 sites, 3H-muscimol binding to GABA sites, or 3H-flunitrazepam binding to benzodiazepine sites.
我们合成了8-甲氧基-2-(N-2'-氯丙基,N-丙基)氨基四氢萘(8-甲氧基-2'-氯-PAT),一种源自强效5-羟色胺(5-HT)激动剂8-羟基-2-(N,N-二丙基)氨基四氢萘(PAT)的烷基化剂。正如不可逆配体所预期的那样,用8-甲氧基-2'-氯-PAT预处理大鼠海马膜后,广泛洗涤膜并不能阻止3H-PAT或3H-5-HT与突触后5-HT1(A和B)位点的结合被阻断。5-HT或PAT预先占据5-HT1位点可防止烷基化剂随后的任何不可逆阻断。在3H-PAT与纹状体膜的结合上也发现了8-甲氧基-2'-氯-PAT类似的不可逆阻断,这表明突触前5-HT结合位点(见戈兹兰等人,《自然》,伦敦,305,140,1983)对烷基化剂也敏感。相比之下,修饰剂N-乙基马来酰亚胺(NEM)显著降低了3H-PAT与突触后海马5-HT1位点的结合,但未改变3H-PAT与纹状体突触前5-HT位点的结合。尽管8-甲氧基-2'-氯-PAT不可逆地结合到不同类型的5-HT结合位点(5-HT1A、5-HT1B、突触前位点),但它可被视为一种选择性烷基化剂,因为它对3H-螺哌隆与5-HT2位点的结合、3H-蝇蕈醇与GABA位点的结合或3H-氟硝西泮与苯二氮䓬位点的结合均无作用。